About 25 Mg Eltrombopag Tablets
Eltroget 25 (Eltrombopag 25 Mg Tablets), marketed by Zydus Biogen Healthcare, is a prodigious solution for rare and inestimable cases of chronic immune thrombocytopenic purpura (ITP), hepatitis C-associated thrombocytopenia, and severe aplastic anemia. Each film-coated, oval, brown tablet offers an unbeatable platelet production boost, ensuring vital support when scarcity of effective options prevails. Supplied in convenient blister packs of 7 tablets, this prescription-only medication must be administered orally and strictly under medical supervision. Add to Cart for a scarce asset to your therapeutic arsenal.
Elite Efficacy for Select Patients
Eltroget 25 tablets bring competitive advantages for adults diagnosed with chronic ITP, hepatitis C-associated thrombocytopenia, or severe aplastic anemia. Physicians rely on Eltroget 25 for its superior effectiveness in stimulating platelet production. The oral dosage form makes it easy for patients to use at home or under supervised care. Prescribed usage is guided by expert recommendations ensuring the safety and optimal health outcomes for eligible individuals.
Reliable Supply, Lowest Proposal and Certifications
Distributors, exporters, suppliers, and traders across India benefit from Eltroget 25's express shipping options, consistent supply ability, and competitive pricing. We offer the lowest price per proposal amount for bulk orders. All batches adhere to strict certifications and regulatory compliance, ensuring quality and reliability. Eltroget 25 is readily available with comprehensive documentation, guaranteeing trusted supply across medical institutions and pharmaceutical channels.
FAQ's of 25 Mg Eltrombopag Tablets:
Q: How should Eltroget 25 tablets be administered?
A: Eltroget 25 tablets are intended for oral administration. Patients should follow their doctor's prescribed dosage and usage recommendations, taking the tablets whole with water as directed.
Q: What are the primary indications for Eltroget 25 usage?
A: Eltroget 25 is indicated for treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura, hepatitis C-associated thrombocytopenia, and severe aplastic anemia.
Q: When is Eltroget 25 contraindicated?
A: Eltroget 25 must not be used in individuals with hypersensitivity to Eltrombopag or any excipient, or in patients with hepatic impairment unless under strict monitoring by healthcare professionals.
Q: Where can Eltroget 25 tablets be sourced in India?
A: Eltroget 25 tablets are distributed, exported, and supplied by certified pharmaceutical traders and suppliers who offer express shipping and authentic product documentation throughout India.
Q: What side effects are associated with the usage of Eltroget 25?
A: Common side effects include nausea, diarrhea, headache, fatigue, and possible alterations in liver function. Close medical monitoring is recommended to manage and mitigate these risks.
Q: How does Eltroget 25 benefit patients with thrombocytopenia?
A: Eltroget 25 effectively stimulates platelet production, providing vital therapeutic advantages for those suffering from chronic ITP or thrombocytopenia related to hepatitis C or severe aplastic anemia.